Dr. Mercy Eigbike, right, a psychiatrist at Carle Foundation Hospital and clinical professor in the Carle Illinois College of Medicine, was the first author of a study that examined bipolar diagnoses ...

A study, published this month in the journal JAMA Psychiatry, sought to determine whether “a single psychedelic dose of psilocybin with psychotherapy demonstrate[s] evidence for efficacy and/or safety ...

October 9, 2012 (Montreal, Canada) — The first 6 months postpartum carry a significantly higher risk for women with major depressive disorder (MDD) to convert to bipolar disorder (BD) compared with ...

A new study led by University of Chicago researchers suggests a significant link between exposure to environmental pollution and an increase in the prevalence of neuropsychiatric disorders. Based on ...

Please provide your email address to receive an email when new articles are posted on . Sunovion and Otsuka announced the first patient has been randomly assigned in their phase 3 clinical study of ...

Baylor College of Medicine received nearly $10 million in funding from the NIH BRAIN Initiative to study effective treatments for the depressive phase of bipolar disorder. In the span of five years, ...

Living with an autoimmune disease is linked to a near doubling in the risk of persistent mental health issues, such as depression, generalised anxiety, and bipolar disorder, with these risks higher in ...

Diagnosing bipolar disorder can be difficult. While it is not hard to distinguish between its two characteristic phases—the high spirits of mania and the low spirits of depression—it is challenging to ...

Publication bias, especially the lack of publication of negative treatment studies, is known to be a major problem in the medical literature. In particular, it appears that the pharmaceutical industry ...